Your browser doesn't support javascript.
loading
Development, initial validation, and application of a visual read method for [18F]MK-6240 tau PET.
Shuping, Joanna L; Matthews, Dawn C; Adamczuk, Katarzyna; Scott, David; Rowe, Christopher C; Kreisl, William C; Johnson, Sterling C; Lukic, Ana S; Johnson, Keith A; Rosa-Neto, Pedro; Andrews, Randolph D; Van Laere, Koen; Cordes, Lindsay; Ward, Larry; Wilde, Claire L; Barakos, Jerome; Purcell, Derk D; Devanand, Davangere P; Stern, Yaakov; Luchsinger, Jose A; Sur, Cyrille; Price, Julie C; Brickman, Adam M; Klunk, William E; Boxer, Adam L; Mathotaarachchi, Sulantha S; Lao, Patrick J; Evelhoch, Jeffrey L.
Afiliação
  • Shuping JL; Enigma Biomedical Group Toronto Ontario Canada.
  • Matthews DC; ADM Diagnostics, Inc. Northbrook Illinois USA.
  • Adamczuk K; Clario, Inc. San Mateo California USA.
  • Scott D; Clario, Inc. San Mateo California USA.
  • Rowe CC; Department of Molecular Imaging and Therapy Austin Health Melbourne Victoria Australia.
  • Kreisl WC; Florey Department of Neuroscience and Mental Health The University of Melbourne Melbourne Victoria Australia.
  • Johnson SC; Department of Neurology The Taub Institute for Research on Alzheimer's Disease and the Aging Brain Columbia University New York New York USA.
  • Lukic AS; Columbia University Irving Medical Center Vagelos College of Physicians and Surgeons New York New York USA.
  • Johnson KA; Department of Medicine Division of Geriatrics Alzheimer's Disease Research Center, University of Wisconsin Madison Wisconsin USA.
  • Rosa-Neto P; ADM Diagnostics, Inc. Northbrook Illinois USA.
  • Andrews RD; The Gordon Center for Medical Imaging Department of Neurology Center for Alzheimer Research and Treatment Brigham and Women's Hospital Boston Massachusetts USA.
  • Van Laere K; Department of Radiology Athinoula A. Martinos Center for Biomedical Imaging Massachusetts General Hospital Harvard Medical School Charlestown Massachusetts USA.
  • Cordes L; Montreal Neurological Institute McGill University Montréal Quebec Canada.
  • Ward L; ADM Diagnostics, Inc. Northbrook Illinois USA.
  • Wilde CL; Nuclear Medicine and Molecular Imaging Department of Imaging and Pathology KU Leuven Leuven Belgium.
  • Barakos J; StatKing Clinical Services Fairfield Ohio USA.
  • Purcell DD; Florey Department of Neuroscience and Mental Health The University of Melbourne Melbourne Victoria Australia.
  • Devanand DP; Cerveau Technologies, Inc. Knoxville Tennessee USA.
  • Stern Y; Clario, Inc. San Mateo California USA.
  • Luchsinger JA; Clario, Inc. San Mateo California USA.
  • Sur C; Department of Neurology The Taub Institute for Research on Alzheimer's Disease and the Aging Brain Columbia University New York New York USA.
  • Price JC; Columbia University Irving Medical Center Vagelos College of Physicians and Surgeons New York New York USA.
  • Brickman AM; Department of Psychiatry Columbia University Irving Medical Center New York New York USA.
  • Klunk WE; Department of Neurology The Taub Institute for Research on Alzheimer's Disease and the Aging Brain Columbia University New York New York USA.
  • Boxer AL; Columbia University Irving Medical Center Vagelos College of Physicians and Surgeons New York New York USA.
  • Mathotaarachchi SS; Department of Psychiatry Columbia University Irving Medical Center New York New York USA.
  • Lao PJ; Department of Neurology Gertrude H. Sergievsky Center Columbia University New York New York USA.
  • Evelhoch JL; Columbia University Irving Medical Center Vagelos College of Physicians and Surgeons New York New York USA.
Alzheimers Dement (N Y) ; 9(1): e12372, 2023.
Article em En | MEDLINE | ID: mdl-36873926
ABSTRACT

Background:

The positron emission tomography (PET) radiotracer [18F]MK-6240 exhibits high specificity for neurofibrillary tangles (NFTs) of tau protein in Alzheimer's disease (AD), high sensitivity to medial temporal and neocortical NFTs, and low within-brain background. Objectives were to develop and validate a reproducible, clinically relevant visual read method supporting [18F]MK-6240 use to identify and stage AD subjects versus non-AD and controls.

Methods:

Five expert readers used their own methods to assess 30 scans of mixed diagnosis (47% cognitively normal, 23% mild cognitive impairment, 20% AD, 10% traumatic brain injury) and provided input regarding regional and global positivity, features influencing assessment, confidence, practicality, and clinical relevance. Inter-reader agreement and concordance with quantitative values were evaluated to confirm that regions could be read reliably. Guided by input regarding clinical applicability and practicality, read classifications were defined. The readers read the scans using the new classifications, establishing by majority agreement a gold standard read for those scans. Two naïve readers were trained and read the 30-scan set, providing initial validation. Inter-rater agreement was further tested by two trained independent readers in 131 scans. One of these readers used the same method to read a full, diverse database of 1842 scans; relationships between read classification, clinical diagnosis, and amyloid status as available were assessed.

Results:

Four visual read classifications were determined no uptake, medial temporal lobe (MTL) only, MTL and neocortical uptake, and uptake outside MTL. Inter-rater kappas were 1.0 for the naïve readers gold standard scans read and 0.98 for the independent readers 131-scan read. All scans in the full database could be classified; classification frequencies were concordant with NFT histopathology literature.

Discussion:

This four-class [18F]MK-6240 visual read method captures the presence of medial temporal signal, neocortical expansion associated with disease progression, and atypical distributions that may reflect different phenotypes. The method demonstrates excellent trainability, reproducibility, and clinical relevance supporting clinical use. Highlights A visual read method has been developed for [18F]MK-6240 tau positron emission tomography.The method is readily trainable and reproducible, with inter-rater kappas of 0.98.The read method has been applied to a diverse set of 1842 [18F]MK-6240 scans.All scans from a spectrum of disease states and acquisitions could be classified.Read classifications are consistent with histopathological neurofibrillary tangle staging literature.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article